Rock Springs Capital Management’s Tempest Therapeutics TPST Stock Holding History

Rock Springs Capital Management’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-41,247	Closed	-$163K	–	115
2023 Q3	$163K	Hold	41,247	–	–	﹤0.01%	116
2023 Q2	$681K	Sell	41,247 -22,111	-35%	-$556K	0.02%	119
2023 Q1	$1.91M	Hold	63,358	–	–	0.05%	105
2022 Q4	$947K	Hold	63,358	–	–	0.02%	112
2022 Q3	$1.43M	Hold	63,358	–	–	0.04%	117
2022 Q2	$1.77M	Hold	63,358	–	–	0.05%	116
2022 Q1	$2.78M	Hold	63,358	–	–	0.07%	121
2021 Q4	$4.35M	Buy	63,358 +39,499	+166%	+$5.44M	0.1%	120
2021 Q3	$4.49M	Hold	23,859	–	–	0.09%	131
2021 Q2	$3.47M	Buy	+23,859	New	+$5.36M	0.07%	139

Other funds holding TPST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Rock Springs Capital Management's TPST Position: Q4 2023 in Review

Rock Springs Capital Management sold out of Tempest Therapeutics (TPST) in Q4 2023, closing a stake of 41,247 shares — an estimated $163K sold.

Rock Springs Capital Management first reported a position in TPST in Q2 2021 and held it in 10 quarters. The position peaked at $4.49M in Q3 2021. 31 funds tracked by Wall St. Rank hold TPST as of Q4 2023.

Rock Springs Capital Management reported no remaining Tempest Therapeutics position as of Q4 2023 after selling out during the quarter.
Rock Springs Capital Management sold 41,247 Tempest Therapeutics shares in Q4 2023, an estimated $163K.
Rock Springs Capital Management first reported a position in Tempest Therapeutics in Q2 2021 and held it in 10 quarters.
Rock Springs Capital Management's Tempest Therapeutics position peaked at $4.49M in Q3 2021.
31 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2023.

Based on Rock Springs Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.